200,000+ products from a single source!

sales@angenechem.com

Home > Other Heterocycles > 27574-24-9

27574-24-9

27574-24-9 | 8-Azabicyclo[3.2.1]octane, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-8-methyl-

CAS No: 27574-24-9 Catalog No: AG002U3B MDL No:

Product Description

Catalog Number:
AG002U3B
Chemical Name:
8-Azabicyclo[3.2.1]octane, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-8-methyl-
CAS Number:
27574-24-9
Molecular Formula:
C22H23NS
Molecular Weight:
333.4897
IUPAC Name:
3-(6H-benzo[c][1]benzothiepin-11-ylidene)-8-methyl-8-azabicyclo[3.2.1]octane
InChI:
InChI=1S/C22H23NS/c1-23-17-10-11-18(23)13-16(12-17)22-19-7-3-2-6-15(19)14-24-21-9-5-4-8-20(21)22/h2-9,17-18H,10-14H2,1H3
InChI Key:
JOQKFRLFXDPXHX-UHFFFAOYSA-N
SMILES:
CN1C2CCC1CC(=C1c3ccccc3SCc3c1cccc3)C2

Properties

Complexity:
496  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
333.155g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
333.493g/mol
Monoisotopic Mass:
333.155g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
28.5A^2
Undefined Atom Stereocenter Count:
2  
Undefined Bond Stereocenter Count:
0
XLogP3:
4.8  

Literature

Title Journal
Total, free and bound leptin and thyroid function in elderly women with different body weights. Clinical endocrinology 20080601
Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. Neuropsychiatric disease and treatment 20080601
[Tropatepine self-poisoning: a case report]. Therapie 20080101
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharmacy world & science : PWS 20070601
[Toxicological analysis in the dawn of the third millenium]. Annales de biologie clinique 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.